Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Oriola

0.75 EUR+0.40 %16/10 17:29
7,766 following

ORIOLA

NASDAQ Helsinki

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Dividend
Short Selling
Investor views
Compare
+0.40 %
-15.40 %
-18.45 %
-21.20 %
-35.04 %
-32.70 %
-18.09 %
-57.27 %
-59.39 %

Oriola is a pharmaceutical group with a particular focus on the distribution of pharmaceuticals to other players in the industry. The company offers services to pharmacies and other pharmaceutical companies, which includes, for example, negotiations with suppliers and distribution of products. The largest operations are in the Nordic and Baltic regions. The headquarters are located in Espoo.

Read more
Market cap
138.44M EUR
Turnover
127.78K EUR
P/E (adj.) (26e)
15.42
EV/EBIT (adj.) (26e)
1.44
P/B (26e)
1.49
EV/S (26e)
0.15
Dividend yield-% (26e)
4.02 %
Coverage
Recommendation
Reduce
Target price
0.80 EUR
Updated
2026-10-05
Disclaimer
Rauli Juva
Rauli Juva

Analyst

Latest research

Latest analysis report

Released: 2026-10-05

Latest extensive report

Released: 2026-06-23

Revenue and EBIT-%
EPS and dividend
Financial calendar
Risk
Business risk
Valuation risk
Low
High
All
Research
Webcasts
Press releases
3rd party
ShowingAll content types

Forum discussions
Indeed, I ended up moving to the “reduce” side on this one, even though the share price is probably at an all-time low and there clearly should be potential for a better / higher valuation in the company. In my view, the risks over the next few years just outweigh the potential upside...
10/5/2026, 6:44 AM
by Rauli_Juva
15
The current CEO has been in their role for about 4 years. Before that, they had a long career at Oriola in other positions. I’d say we’ve pretty much seen what they’re capable of by now, and it’s time (once again) to look for someone who could actually turn this train wreck of a ...
10/1/2026, 7:09 AM
by TitoK
14
It feels rather impossible that Gabrielsson could continue heading Oriola for very long after this. Because of the previous ERP mess that made nationwide news, this project must have been under particularly close monitoring, and yet they still managed to screw it up in terms of both...
10/5/2026, 6:47 AM
by mikde
13
This really is something burned my own fingers with Oriola years ago. You could definitely make a good case study out of this Oriola thread, or one of those “investing lessons learned the hard way.” Let me break it down a bit: Macroeconomics provides favorable tailwinds (growing ...
10/2/2026, 11:05 AM
by Saunatonttu
12
Here are some comments on that, the price tag of the delay is truly shocking. At the same time, the partner changed, which of course indicates that the beginning of the project did not go as desired and partly explains the additional costs. But it’s better to pay these costs at this...
10/1/2026, 6:26 AM
by Rauli_Juva
11
Only now catching up after work to see why Oriola is dropping on the stock market… How can running such a rock-solid business be this difficult?!? In practice, Oriola only has one competitor, Tamro. And this business isn’t rocket science—you handle pharmaceutical logistics. The current...
10/1/2026, 3:02 PM
by Lohis
10
Haven’t followed this company in years, since the new systems and distribution were thoroughly screwed up. And what on earth, I saw the stock dropping and wondered what now—turns out it’s the exact same fumbling year after year. Just make a deal with Wolt, even that would work out...
10/1/2026, 7:22 AM
by Raikku
7
Read more on our forum
Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
29/10
2026

Interim report Q3'26

23/2
2027

Annual report '26

24/3
2027

General meeting '27

Press release2026-10-15 08:00

Oriola Oyj: Oriola Corporation to publish its Interim Report for January-September 2026 on 29 October 2026

Oriola
Oriola, Webcast, Q3'26
Webcast2026-10-29 09:00

Oriola, Webcast, Q3'26

Oriola
Oriola: Risks weigh on the coming years
Research2026-10-05 07:34 by
Rauli Juva

Oriola: Risks weigh on the coming years

The prolonged IT system renewal means that, in our view, a sustainable earnings improvement will only be possible by 2029.

Oriola

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Oriola: Förseningen av ERP-reformen medför betydande tilläggskostnader
Analyst Comment2026-10-01 08:20 by
Rauli Juva

Oriola: Förseningen av ERP-reformen medför betydande tilläggskostnader

En extra räkning på nästan 20 MEUR och en försening av ERP-projektet till 2028 sänker de rapporterade vinstestimaten.

Oriola
Press release2026-10-01 07:30

Oriola Oyj: Oriola updates timeline and investment of ERP and warehouse management programme

Oriola
Regulatory press release2026-09-24 11:15

Correction: Oriola Corporation: Notification of a change in shareholding according to Chapter 9, Section 10 of the Securities Market Act

Oriola
Regulatory press release2026-09-23 16:00

Oriola Corporation: Notification of a change in shareholding according to Chapter 9, Section 10 of the Securities Market Act

Oriola
Regulatory press release2026-09-18 08:00

Oriola Oyj: Oriola has corrected previously reported financial information

Oriola
Regulatory press release2026-09-17 08:00

Oriola Oyj: Publication schedule for Oriola Corporation's financial reporting in 2027

Oriola
VD-intervju: Ny strategi, skarpare mål till 202914:50
Video2026-09-09 09:20 by
Jesper Hagman

VD-intervju: Ny strategi, skarpare mål till 2029

Vi träffade bolaget för att prata om vad som ligger bakom målen om minst 5 procents årlig tillväxt, synen på Kronans Apotek samt hur vägen framåt ser ut.

Oriola
Oriola Q2'26: Trög utveckling
Research2026-07-20 06:25 by
Rauli Juva

Oriola Q2'26: Trög utveckling

Vi estimerar att företaget med svårighet kommer att nå sin guidning om resultatförbättring för helåret.

Oriola
Oriola Q2'26: Headwinds from higher freight costs6:42
Video2026-07-17 11:42 by
Rauli Juva

Oriola Q2'26: Headwinds from higher freight costs

Higher freight costs and increased operating expenses weighed on Oriola's earnings in Q2. Meanwhile, associate company Kronans improved its result compared with the corresponding period last year.

Oriola
Oriola, Webcast, Q2'26
Webcast2026-07-17 09:00

Oriola, Webcast, Q2'26

Oriola
Oriola Q2'26 snabbkommentar: Resultatet låg i nivå med jämförelseperioden
Analyst Comment2026-07-17 08:05 by
Rauli Juva

Oriola Q2'26 snabbkommentar: Resultatet låg i nivå med jämförelseperioden

Oriolas Q2-rapport var operationellt sett något svagare än våra förväntningar, då företagets justerade EBITDA låg kvar på jämförelseperiodens nivå och var något lägre än våra estimat.

Oriola
Regulatory press release2026-07-17 07:30

Oriola Oyj: Oriola Corporation's Half-Year Report 1 January-30 June 2026

Oriola
Oriola Q2'26 förhandskommentar: Måttlig dos av vinsttillväxt
Analyst Comment2026-07-07 07:00 by
Rauli Juva

Oriola Q2'26 förhandskommentar: Måttlig dos av vinsttillväxt

Vi estimerar att den justerade EBITDA kommer att stiga något till 8,5 MEUR i och med resultatförbättringen inom Products-segmentet.

Oriola
Press release2026-07-03 08:00

Oriola Oyj: Oriola Corporation to publish its Half-Year Report for January-June 2026 on 17 July 2026

Oriola
Oriola Extensive Report: Patience prescribed
Extensive research2026-06-23 11:15 by
Rauli Juva

Oriola Extensive Report: Patience prescribed

Oriola's stock looks cheap, but there are clear risks associated with both the balance sheet and operational activities.

Oriola
Regulatory press release2026-06-12 16:00

Oriola Oyj: Oriola's share buyback programme has been completed

Oriola
Regulatory press release2026-06-10 18:00

Oriola Oyj: Acquisition of own shares during week 24, 2026

Oriola